Diabetic nephropathy arises from sustained hyperglycaemia and hypertension that induce structural and functional alterations across the glomerular and tubulointerstitial compartments of the kidney.
No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the ability of kidney cells to filter blood. Recently, researchers at the GOFARR Laboratory ...
IgA nephropathy is the most prevalent primary glomerulonephritis worldwide, characterised by deposition of immunoglobulin A (IgA), predominantly the IgA1 subclass, within the renal mesangium. A ...
The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary immunoglobulin A (IgA) nephropathy, maker Novartis announced late on Wednesday.
Chronic kidney disease affects more than 850 million people worldwide and continues to impose a heavy clinical and economic ...
Panelists discuss how current immunoglobulin A (IgA) nephropathy treatments primarily target downstream inflammatory pathways of the 4-hit cascade, with emerging therapies now beginning to address ...
Diabetic nephropathy develops slowly over several years. There may be no symptoms in its early stages. Treatment may prevent it from progressing and leading to serious conditions, like end stage renal ...
Phase 3 VISIONARY study met its primary endpoint at the prespecified interim analysis; sibeprenlimab demonstrated a statistically significant and clinically meaningful reduction in 24-hour uPCR after ...
High-impact biological discoveries often hinge on access to the right antibodies at the right time. However, commercially available antibodies are not always available or well-suited for translational ...
Research shows semaglutide — commonly sold as Ozempic or Wegovy — can improve kidney function and survival rates for people ...
A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the progression of diabetic nephropathy (DN) and explores its potential ...
No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the ability of kidney cells to filter blood. Recently, researchers at the GOFARR Laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results